The Inherited Disease Panel simultaneously analyzes the biomarkers for the pathogenesis of inherited diseases. All 2,742 DNA regions in our Inherited Disease Panel are directly implicated in inherited disorders.

Inherited Disease Panel

Why use Inherited Disease Panel?

Determine the causative gene of a disorder
Global research efforts are ungoing to finding new biomarkers in order to better understand the genetic basis of inherited diseases. For roughly 4,000 disorders, a clear genetic defect has been identified.
This knowledge is combined in our Inherited Disease Scan that simultaneously analyzes the 2,742 genes that are directly implicated in these inherited disorders.
There are currently over 7,000 known rare inherited diseases. Though not frequently occurring, collectively they affect ~8% of the general population.
The syndromic nature, highly variable penetrance and expressivity of these disorders make disease classification and candidate gene identification challenging. The Inherited Disease Panel has a great advantage over traditional techniques that test only one or a few genes for each rare disease separately.
By measuring all 2,742 gene regions in one test, you can quickly determine the causative gene or rule out many disorders characterized by similar symptoms. The Inherited Disease Panel can save precious time and costs. Provide your patient with an accurate diagnosis within 5 to 6 weeks.
Reporting
We provide ordering physicians with a comprehensive report letter. Clinical laboratory geneticists interpret the data using the most up to date scientific information and literature.
Screening of patients
Many (academic) partners request the Inherited Disease Scan for large numbers of patients. The data can be generated rapidly and transferred to your institute as raw data. Extensive data-control is included to ensure that the data-quality is according to our high standards as set by ISO 17025 regulations. You can request the Focused Inherited Disease Scan and filter each data-set based on your genes of interest.

Robust and high coverage
The hybridization probes of the Focused Inherited Disease Panel are developed in collaboration with researchers from Medical Genetics, Charite Berlin. All probes are reviewed extensively, resulting in a robust test with high coverage throughout the panel. We can guarantee profiling variants in at least 93% of the targeted genes with a minimal coverage of 30x.
Exome Diagnostics: for interpretation of even more genes
When your clinical question needs interpretation of the total exome, we offer Exome Diagnostics to interrogate all ~20,000 protein-coding genes.
Other Services
Let's get the conversation started for your next NGS project
Please either fill in this form of email us directly at info@genomescan.nl
and we will get in touch with you to discuss your requirements